BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Breast
,
Laser capture microdissection
,
Bleomycin
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ara c
Summary
General Info
Curated Studies
Most Correlated Studies
Acute lymphoblastic leukemia NALM-6 xenografts treated with cytarabine (Ara-C)
Acute myeloid leukemia cell lines selected for high resistance to Ara-C
Pre-B ALL Reh cells co-cultured with bone marrow stromal cells and treated with Ara-C
Cytosine arabinoside (Ara-C) resistance in acute myeloid leukemia (AML) cell lines
AML xenografts treated with a combination of decitabine and cytarabine
Explore Curated Studies Results
Literature
Most Relevant Literature
A successful desensitization in an adult patient with ARA-C infusion reaction.
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial ther…
Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.
Transfer of IGF2BP3 Through Ara-C-Induced Apoptotic Bodies Promotes Survival of Recipient Cells.
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
Azacytidine With Valproic Acid Versus Ara-C in Acute Myeloid Leukemia (AML)/ Myelodysplastic Syndrom…
Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML
Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ